POSTER: AML-516 KOMET-007 Trial in Progress: A Phase I Study of Ziftomenib in Combination With Venetoclax or Venetoclax/Azacitidine, or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination With Ziftomenib, for the Treatment of Patients With Acute Myeloid Leukemia

Autor: Zeidan, Amer, Fathi, Amir, Issa, Ghayas, Erba, Harry, Ahsan, Julie Mackey, Corum, Daniel, Tomkinson, Blake, Kozlek, Tom, Leoni, Mollie, Wang, Eunice
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S171-S171
Databáze: ScienceDirect
Externí odkaz: